A pooled analysis of mesenchymal stem cell-based therapy for liver disease

BACKGROUND: Liver disease is a major cause of death and disability. Mesenchymal stem cells (MSCs) show promise for the treatment of liver disease. However, whether MSC-based therapy is more effective than conventional treatment is unclear, as are the optimal MSC source, the administration frequency,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Lu, Chen, Shanquan, Shi, Xiaowei, Cao, Hongcui, Li, Lanjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863358/
https://www.ncbi.nlm.nih.gov/pubmed/29562935
http://dx.doi.org/10.1186/s13287-018-0816-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863358/
https://www.ncbi.nlm.nih.gov/pubmed/29562935
http://dx.doi.org/10.1186/s13287-018-0816-2

Ejemplares similares